在杆菌根除方面,治疗方面的进步和未来方向
Vidya Suresh1, Amritavarshini Sreekumar1, Anil Kumar2
1Amrita School of Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
Frontiers in microbiology
|December 19, 2025
概括
管理杆菌 (H. pylori) 需要适应抗生素耐药性的上升. 新疗法,包括四重疗法和新药,以及益生菌和植物化学品等补充策略,提供了更好的全球根除.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 杆菌 (H. pylori) 感染是全球胃肠道疾病的主要原因之一.
- 对标准疗法的抗生素耐药性,如基于克拉里胺的三重疗法,在全球范围内正在增加.
- 根据局部耐药性模式量身定制治疗对于有效的H. pylori根除至关重要.
研究的目的:
- 审查当前的临床证据和H. pylori管理的新兴创新.
- 强调传统和下一代治疗方法的整合.
- 讨论可持续全球H. pylori控制的战略.
主要方法:
- 审查最近的临床试验和临床前研究.
- 对优化的四重疗法进行分析,包括基于慕和诺普拉桑的疗法.
- 评估新药,辅助策略 (益生菌,植物化学品) 和替代方法.
主要成果:
- 优化的四重疗法和抗性导向治疗正在改变临床实践.
- 像Rifasutenizol这样的新型药物显示出对抗多药耐药H. pylori菌株的希望.
- 辅助疗法 (益生菌,植物化学品) 在改善根除和减少副作用方面表现出协同作用.
结论:
- 既定和新型疗法的平衡整合对于可持续的全球H. pylori管理至关重要.
- 基于局部抗生素敏感性的个性化治疗策略越来越重要.
- 新兴的方法为克服抗生素耐药性和改善患者结果提供了希望.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Peptic Ulcer Disease IV: Management
401
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
401
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
507
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
507
Gastritis III: Clinical Manifestations and Management
1.1K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.1K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
895
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
895
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
819
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
819


